Inventor · disambiguated record
Elizabeth Joseloff
Also filed as: JOSELOFF ELIZABETH · JOSELOFF ELIZABETH G
6 granted patents·10 pending applications·233 citations·filing 2006–2021
87Inventor score
Top patents by PatentIndex Score
16 records- 0196US7608413B1Kidney disease targets and uses thereofCELERA CORP·Filed 2007·Granted Oct 27, 2009·88 cites·4 claims
- 0295US7807392B1Lung disease targets and uses thereofCELERA CORP·Filed 2007·Granted Oct 5, 2010·74 cites·5 claims
- 0394US7521195B1Lung disease targets and uses thereofCELERA CORP·Filed 2006·Granted Apr 21, 2009·38 cites·3 claims
- 0492US7842291B1Methods and compositions for diagnosing and treating diseasesCELERA CORP·Filed 2007·Granted Nov 30, 2010·14 cites·4 claims
- 0591US7998689B2Detection of CXADR protein for diagnosis of kidney cancerCELERA CORP·Filed 2009·Granted Aug 16, 2011·15 cites·3 claims
- 0679US7611703B1Kidney disease targets and uses thereofCELERA CORP·Filed 2007·Granted Nov 3, 2009·4 cites·5 claims
- 0776US2021277073A1Kidney disease targets and uses thereofCELERA CORP·Filed 2021·Application pending·0 cites
- 0870US2020276329A1Methods and compositions for treating and diagnosing diseasesCELERA CORP·Filed 2020·Application pending·0 cites
- 0967US2019233484A1Kidney disease targets and uses thereofCELERA CORP·Filed 2018·Application pending·0 cites
- 1066US2017350897A1Methods and compositions for treating and diagnosing diseasesCELERA CORP·Filed 2017·Application pending·0 cites
- 1164US2014314770A1Kidney disease targets and uses thereofCELERA CORP·Filed 2014·Application pending·0 cites
- 1262US2009232822A1Lung disease targets and uses thereofCELERA CORP·Filed 2009·Application pending·0 cites
- 1360US2016362461A1Kidney disease targets and uses thereofCELERA CORP·Filed 2016·Application pending·0 cites
- 1456US2012183552A1Kidney disease targets and uses thereofJOSELOFF ELIZABETH·Filed 2011·Application pending·0 cites
- 1548US2011212085A1Lung cancer disease targets and uses thereofCELERA CORP·Filed 2010·Application pending·0 cites
- 1643US2011219464A1Lung disease targets and uses thereofCELERA CORP·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →